Page 2319 - Williams Hematology ( PDFDrive )
P. 2319

2292  Part XII:  Hemostasis and Thrombosis  Chapter 134:   Atherothrombosis: Disease Initiation, Progression, and Treatment  2293




                  restoration of hemostatic balance that promotes blood fluidity along   As noted above in the section on “Pathobiology of Arterial Thrombi,”
                  healthy endothelial surfaces immediately adjacent to the site of injury.   plaque rupture and the development of new intimal surface irregulari-
                  Thrombus propagation may occur, however, through a bloodborne pool   ties also suddenly alter local rheologic characteristics, increasing local
                  of thrombogenic substances that originate at the site of vascular injury   shear rates. Increased shear stress resulting from sudden changes in
                  and thrombosis. These substances can be in the form of platelets, leuko-  degree of stenosis following rupture is compounded by increased focal
                  cytes, red cells, sloughed endothelial cells, other cellular microparticles,   vasoconstriction  induced  by  thrombin, thromboxane  A ,  and other
                                                                                                                  2
                  and circulating active TF derived from leukocytes activated within the   vasoactive substances released in the milieu of acute injury.
                                                  176
                                                                                                –1
                  thrombus. 174,175  In fact, cellular microparticles  constitute the main res-  At high shear rates (>1000 s ), platelets must be initially tethered
                  ervoir of bloodborne TF, the principal initiator of coagulation.  to the vascular surface through a shear-activated interaction between
                     Thrombus persistence within an artery depends on the local bal-  the platelet membrane GPIbα (of the GPIb–IX–V complex) and its
                  ance between prothrombotic, antithrombotic, and fibrinolytic factors.   adhesive ligand, VWF. 187–189  Platelet adhesion also involves collagen
                  Ulcerated and thrombotic atherosclerotic plaques, particularly in the   binding to platelet collagen receptors (integrin α β  and GPVI). Other
                                                                                                            2 1
                                        177
                  aorta, tend to persist or recur.  Atherosclerotic plaques of the aortic   matrix constituents that become exposed to platelets and serve as adhe-
                  arch have been detected in almost one-third of patients with crypto-  sive ligands include fibronectin, laminin, fibrinogen, and fibrin. These
                  genic stroke. Although aortic arch atheroma are more frequent and   initial adhesive interactions induce intracellular signaling pathways
                  more severe causes of cryptogenic stroke in individuals older than     that  activate  platelets.  High shear stress  also  activates  platelets  both
                                                                              190
                  55 years of age, patent foramen ovale (and presumably paradoxical   directly,  as noted previously, and by lowering the threshold of platelet
                  embolism) are more strongly associated with cryptogenic stroke in   activation by chemical agonists to which platelets are simultaneously
                  those younger than 55 years of age. 178               exposed in the microenvironment of the arterial thrombus.  Thus, fol-
                                                                                                                   191
                     Advances in the development of coronary stents have created   lowing adhesion, platelets are explosively activated by several interact-
                  a new form of arterial thrombosis that usually can only be prevented   ing pathways: (1) intracellular signaling initiated by the adhesion event
                  by administration of two different platelet inhibitors (e.g., aspirin in   itself, (2) direct action of locally increased shear stress, and (3) agonists
                  combination with a thienopyridine derivative, such as clopidogrel or   released (e.g., ADP, thromboxane A ) and generated (e.g., thrombin) at
                                                                                                  2
                  prasugrel). Although drug-eluting stents that deliver sirolimus or pacl-  the site of vascular injury.
                  itaxel have been successful in reducing the problem of restenosis that   Finally, the occlusive arterial platelet thrombus is created by the
                  is caused by smooth muscle cell proliferation and intimal hyperplasia   aggregation of platelets. This process is mediated by several alterna-
                  following the coronary intervention, they have actually increased the   tive ligands (VWF, fibrinogen, fibronectin) that bind to their activated
                  occurrence of “late stent thrombosis” compared to bare metal stents.   receptors in the platelet integrin α β  complex. Stability of the plate-
                                                                                                  IIb 3
                  This form of arterial thrombosis, which typically occurs after discontin-  let aggregate is conferred by additional ligand–receptor interactions,
                                                                                                       192
                  uation of (dual) antiplatelet therapy, is probably caused by eluting drugs   including CD40L binding to integrin α β .  Platelet thrombus stabili-
                                                                                                    IIb 3
                  interfering with endothelialization of the stent surface. 179  zation is designed to counteract shear forces that promote not only the
                     Thrombosis in Nonatherosclerotic Arteries  Thrombosis may   formation of arterial thrombi but also their embolization.
                                                     180
                  occur in arteries that are affected by vasculitis.  As both SLE and   The importance of the inflammatory component of arterial throm-
                  atherosclerosis are immune-driven processes, it is to be expected   bosis,  which is characterized by complex interactions among leuko-
                                                                            164
                  that some patients with active SLE are more susceptible to acceler-  cytes, endothelial cells, and platelets, is increasingly being recognized.
                  ated atherosclerosis (and related atherothrombosis) resulting from     Activated platelets recruit leukocytes to the site of vascular damage,
                  autoantibody-mediated proatherogenic mechanisms. 181,182  However,   promoting their adhesion to endothelium and their activation on endo-
                  even in the absence of underlying atherosclerosis, various types of     thelium-bound chemokines. In fact, the presence of leukocytosis in
                  arterial thrombosis can complicate active vasculitis. For example,   myeloproliferative neoplasms is a better predictor of pathologic throm-
                  patients with SLE may have MI with angiographically normal coronary   bosis than the platelet count.
                  arteries. Giant cell arteritis, which characteristically targets the extracra-
                  nial carotid and vertebral arteries, leads to inflammation and necrosis   Tissue Factor and Phospholipids
                  of the arterial wall and subsequent arterial occlusions in a distribution   Tissue factor is a cell-surface–bound transmembrane protein that nor-
                  that is quite different from that of atherosclerosis. Takayasu arteritis has   mally is not exposed to circulating blood. When expressed, TF initiates
                  an unusual predilection for the aortic arch and its branches, leading to   coagulation by binding to factor VIIa and activates factors IX and X,
                  panarteritis, medial layer enlargement with luminal narrowing, and   thereby triggering the common pathway of coagulation and the for-
                  sometimes thrombotic occlusion. Other types of vasculitis and autoim-  mation of thrombin. Strong evidence indicates that TF is the principal
                  mune processes that may cause arterial thrombosis include polyarteritis   thrombogenic factor in the lipid-rich core of atherosclerotic plaques.
                  nodosa, Behçet disease, and antiphospholipid antibody syndrome.  While much of this TF is associated with monocytes/macrophages and
                     Arterial thrombosis in the absence of atherosclerosis is also seen   vascular  smooth  muscle  cells,  more  recent  studies  suggest  that TF-
                  with immune- and nonimmune disorders of platelets and/or the vas-  positive microparticles are the most abundant sources of TF in athero-
                  cular endothelium, such as heparin-induced thrombocytopenia (with   sclerotic plaques. The main inhibitor of TF-mediated coagulation is
                  arterial thrombosis most commonly occurring in the aorta, iliofemoral   TFPI. In atherosclerotic plaques TFPI colocalizes with TF and therefore
                  arteries, as well as in cerebral and coronary arteries),  and in the mye-  may play an atheroprotective role. 162,193
                                                        183
                  loproliferative neoplasms (e.g., essential thrombocythemia, polycythe-  Upon rupture of the atherosclerotic plaque, exposure of vascular TF
                  mia vera; Chaps. 84 to 86). 184–186                   to flowing blood initiates the coagulation cascade. Coagulation reactions
                                                                        are accelerated on the surfaces of activated platelets, microparticles, and
                  Platelet Activation                                   on other activated cells in the microenvironment of vascular injury. The
                  Disruption of an advanced atherosclerotic plaque results in abrupt   surfaces of these activated cells express anionic phospholipids, particu-
                  exposure of highly thrombogenic material to flowing blood. This pro-  larly phosphatidylserine. Apoptotic cells, with which advanced lesions
                  cess leads locally to both thrombin generation and platelet activation,   are enriched, likewise translocate phospholipids from the inner to the
                                                                                                 194
                  which  operate simultaneously  in a  mutually self-amplifying  process.   outer leaflet of the cell membrane.  Plasma lipoproteins can provide a





          Kaushansky_chapter 134_p2281-2302.indd   2293                                                                 17/09/15   3:49 pm
   2314   2315   2316   2317   2318   2319   2320   2321   2322   2323   2324